| The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed … C Vlachopoulos, P Xaplanteris, V Aboyans, M Brodmann, R Cífková, ... Atherosclerosis 241 (2), 507-532, 2015 | 933 | 2015 |
| Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan EL Schiffrin, JB Park, HD Intengan, RM Touyz Circulation 101 (14), 1653-1659, 2000 | 824 | 2000 |
| Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR X Chen, RM Touyz, JB Park, EL Schiffrin Hypertension 38 (3), 606-611, 2001 | 562 | 2001 |
| Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension JB Park, EL Schiffrin Journal of hypertension 19 (5), 921-930, 2001 | 478 | 2001 |
| Chronic treatment with a superoxide dismutase mimetic prevents vascular remodeling and progression of hypertension in salt-loaded stroke-prone spontaneously hypertensive rats JB Park, RM Touyz, X Chen, EL Schiffrin American journal of hypertension 15 (1), 78-84, 2002 | 240 | 2002 |
| Validation of non-invasive central blood pressure devices: ARTERY Society task force consensus statement on protocol standardization JE Sharman, AP Avolio, J Baulmann, A Benetos, J Blacher, CL Blizzard, ... European heart journal 38 (37), 2805-2812, 2017 | 238 | 2017 |
| Correlation of endothelial function in large and small arteries in human essential hypertension. JB Park, F Charbonneau, EL Schiffrin Journal of hypertension 19 (3), 415-420, 2001 | 233 | 2001 |
| Effect of crossing over hypertensive patients from a beta-blocker to an angiotensin receptor antagonist on resistance artery structure and on endothelial function EL Schiffrin, JB Park, Q Pu Journal of hypertension 20 (1), 71-78, 2002 | 187 | 2002 |
| ETA Receptor Antagonist Prevents Blood Pressure Elevation and Vascular Remodeling in Aldosterone-Infused Rats JB Park, EL Schiffrin Hypertension 37 (6), 1444-1449, 2001 | 174 | 2001 |
| NAD (P) H oxidase inhibitor prevents blood pressure elevation and cardiovascular hypertrophy in aldosterone-infused rats YM Park, MY Park, YL Suh, JB Park Biochemical and biophysical research communications 313 (3), 812-817, 2004 | 163 | 2004 |
| Systolic hypertension: an increasing clinical challenge in Asia JB Park, K Kario, JG Wang Hypertension Research 38 (4), 227-236, 2015 | 157 | 2015 |
| Cardiac and vascular fibrosis and hypertrophy in aldosterone-infused rats: role of endothelin-1 JB Park, EL Schiffrin American journal of hypertension 15 (2), 164-169, 2002 | 151 | 2002 |
| Effect of amlodipine compared to atenolol on small arteries of previously untreated essential hypertensive patients EL Schiffrin, Q Pu, JB Park American journal of hypertension 15 (2), 105-110, 2002 | 140 | 2002 |
| Role of c-Src in the regulation of vascular contraction and Ca2+ signaling by angiotensin II in human vascular smooth muscle cells RM Touyz, XH Wu, G He, JB Park, X Chen, J Vacher, V Rajapurohitam, ... Journal of hypertension 19 (3), 441-449, 2001 | 123 | 2001 |
| Src is an important mediator of extracellular signal–regulated kinase 1/2–dependent growth signaling by angiotensin II in smooth muscle cells from resistance arteries of … RM Touyz, G He, XH Wu, JB Park, ME Mabrouk, EL Schiffrin Hypertension 38 (1), 56-64, 2001 | 121 | 2001 |
| 2013 Korean Society of Hypertension guidelines for the management of hypertension. Part II—treatments of hypertension J Shin, JB Park, K Kim, JH Kim, DH Yang, WB Pyun, YG Kim, GH Kim, ... Clinical Hypertension 21, 1-13, 2015 | 120* | 2015 |
| Association of high sensitivity C-reactive protein with coronary heart disease prediction, but not with carotid atherosclerosis, in patients with hypertension H Choi, DH Cho, HH Shin, JB Park Circulation Journal 68 (4), 297-303, 2004 | 103 | 2004 |
| Reduction of resistance artery stiffness by treatment with the AT1-receptor antagonist losartan in essential hypertension JB Park, HD Intengan, EL Schiffrin Journal of the renin-angiotensin-aldosterone system 1 (1), 40-45, 2000 | 97 | 2000 |
| Association of angiotensin-converting enzyme and angiotensinogen gene polymorphisms with preeclampsia H Choi, JY Kang, HS Yoon, SS Han, CS Whang, IG Moon, HH Shin, ... Journal of Korean medical science 19 (2), 253-257, 2004 | 94 | 2004 |
| A prospective study of fatty liver index and incident hypertension: the KoGES-ARIRANG study JH Huh, SV Ahn, SB Koh, E Choi, JY Kim, KC Sung, EJ Kim, JB Park PLoS One 10 (11), e0143560, 2015 | 90 | 2015 |
Ernesto L. SchiffrinProfessor, Department of Medicine, McGill Universityכתובת אימייל מאומתת בדומיין mcgill.ca